FINWIRES · TerminalLIVE
FINWIRES

美国银行:英国央行将在4月会议上维持关键利率不变;6月和7月或将加息

By

-- 美国银行全球研究部预计,英国央行将在4月30日的货币政策会议上维持3.75%的关键利率不变,预计7比2的投票结果支持维持利率不变,但也存在8比1的投票结果的可能性。 分析师在周四发布的预览报告中表示:“央行可能会注意到,中期通胀持续性增强带来的上行风险有所上升,而经济增长放缓的风险依然存在。鉴于不确定性,我们预计英国央行不会就加息或长期维持利率不变做出明确的判断。” “但我们预计,如果能源价格持续高企,央行仍将保留小幅加息的可能性,并认为鉴于劳动力市场和经济增长方面的担忧,大幅收紧货币政策的可能性不大。我们预计央行将排除近期降息的可能性。” 展望未来,该研究机构预测,英国央行将在2026年6月和7月两次上调基准利率,但也存在仅加息一次的风险,并指出“情况非常复杂”。 预计从 2027 年第二季度开始,将连续三个季度降息至 3.5%,并存在降至 3.25% 的风险。

Related Articles

Asia

Biocytogen Pharmaceuticals Turns to Profit in Q1

Biocytogen Pharmaceuticals (Beijing) (HKG:2315) recorded an attributable profit of 104 million yuan in the first quarter of 2026, compared with an attributable loss of 13.2 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share stood at 0.23 yuan, compared with a loss per share of 0.03 yuan in the corresponding period of the previous fiscal year.Operating revenue jumped 74% in the three months to 433.1 million yuan from 249.3 million yuan in the year-ago period, driven by a substantially higher revenue contribution from pharmacology and efficacy services and animal models.The pharmaceutical company attributed the higher profit mainly to revenue growth and improved operating efficiency amid expense management.

$HKG:2315
Oil & Energy

Market Chatter: LNG Carrier Orders Surge as Global Output Defies Iran War Tensions

Global demand for liquefied natural gas carriers is rebounding sharply in 2026, despite the ongoing US-Iran conflict, Reuters reported Monday, citing analysts and industry experts.Analysts report that surging LNG production and a transition toward high-efficiency vessels are fueling the recovery.According to the report, Shipbuilders in South Korea and China have already secured 35 new build contracts in Q1 alone.The resurgence in construction comes despite the escalating US-Iran war, which has choked the Strait of Hormuz and raised fears of a prolonged shipping downturn.However, market experts suggest that the need for modern, fuel-efficient tonnage is outweighing immediate freight rate concerns, it said.These new vessels, which cost between $250 million and $260 million and take over three years to complete, are increasingly necessary as older, steam-propelled tankers are scrapped at record rates to meet stricter global emissions regulations.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Research

Canaccord Genuity Initiates Coverage on Structure Therapeutics With Buy Rating, $101 Price Target

Structure Therapeutics (GPCR) has an average rating of Buy and mean price target of $108.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$GPCR